Eyepoint Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Eyepoint Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eyepoint Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eyepoint Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $570k | 25k | 23.11 |
| 2023-09-30 | $4.9M | 609k | 7.99 |
| 2023-06-30 | $185k | 21k | 8.70 |
| 2023-03-31 | $62k | 21k | 2.95 |
| 2022-12-31 | $55k | 16k | 3.52 |
| 2022-06-30 | $124k | 15k | 8.00 |
| 2022-03-31 | $191k | 16k | 12.15 |
| 2021-12-31 | $136k | 11k | 12.21 |
| 2021-03-31 | $1.2k | 120 | 10.00 |
| 2020-12-31 | $0 | 20 | 0.00 |